´Ù°¡ºÒÆ÷ÈÁö¹æ»ê ½ÃÀåÀº ¿¬Æò±Õ 8.13%ÀÇ CAGR·Î »ó½ÂÇÏ¿© 2022³â 107¾ï 1,700¸¸ ´Þ·¯¿¡¼ 2029³â 185¾ï 2,700¸¸ ´Þ·¯ÀÇ ½ÃÀå °¡Ä¡¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
½ÄÀÌ Áö¹æÀÇ ÀÏÁ¾ÀÎ ´Ù°¡ºÒÆ÷ÈÁö¹æÀº ´ÜÀÏºÒÆ÷ÈÁö¹æ°ú ÇÔ²² À¯ÀÍÇÑ Áö¹æÀ¸·Î ºÐ·ùµË´Ï´Ù. ÀÌ Áö¹æÀº ¿¬¾î, ½Ä¹°¼º ±â¸§, ¾ö¼±µÈ °ß°ú·ù¿Í ¾¾¾Ñ·ù µî ½Ä¹°¼º ¹× µ¿¹°¼º ½Äǰ¿¡ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù. Æ÷ÈÁö¹æ»ê°ú Æ®·£½ºÁö¹æ»ê ´ë½Å ´Ù°¡ºÒÆ÷ÈÁö¹æ»ê(´ÜÀÏºÒÆ÷ÈÁö¹æ»êµµ ¸¶Âù°¡Áö)À» Àû´çÈ÷ ¼·ÃëÇÏ´Â °ÍÀº Àü¹ÝÀûÀÎ °Ç°¿¡ µµ¿òÀÌ µË´Ï´Ù.
´Ù°¡ºÒÆ÷ÈÁö¹æ»ê¿¡´Â ¿À¸Þ°¡ 3 Áö¹æ»ê°ú ¿À¸Þ°¡6 Áö¹æ»êÀ̶ó´Â Çʼö Áö¹æ»êÀÌ Æ÷ÇԵ˴ϴÙ. ¿À¸Þ°¡ 3 Áö¹æ»ê°ú ¿À¸Þ°¡6 Áö¹æ»êÀº ³ú ±â´É°ú ¼¼Æ÷ ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Çʼö Áö¹æ»êÀº ü³»¿¡¼ »ý¼ºµÇÁö ¾Ê±â ¶§¹®¿¡ À½½ÄÀ¸·Î ¼·ÃëÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. ºÒÆ÷ÈÁö¹æ»ê »ê¾÷¿¡´Â ½Äǰ, °Ç°º¸Á¶½Äǰ, ÀǾàǰ, »ç·á µîÀÌ ÀÖ½À´Ï´Ù.
´Ù°¡ºÒÆ÷ÈÁö¹æ»êÀº ¿À¸Þ°¡ 3¿Í ¿À¸Þ°¡6·Î ºÐ·ùµË´Ï´Ù. ÀÌ·¯ÇÑ ±¸ºÐÀº À̵é Áö¹æ»êÀÌ °Ç° ÁõÁø¿¡ ¹ÌÄ¡´Â ´Ù¾çÇÑ ¿ªÇÒÀ» ¹Ý¿µÇÕ´Ï´Ù. ¶ÇÇÑ, ºÒÆ÷ÈÁö¹æ»ê ½ÃÀåÀº ¼ÒºñÀÚ¿¡°Ô ´Ù¾çÇÑ ¼±ÅñÇÀ» Á¦°øÇϱâ À§ÇØ Çüź°·Î ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. Á¤Á¦, ¾×»ó, ¼ÒÇÁÆ®Á©, ºÐ¸» µî ´Ù¾çÇÑ ±âÈ£³ª ¼·Ãë ÆíÀǼºÀ» °í·ÁÇÑ ´Ù¾çÇÑ ÇüŰ¡ ÀÖ½À´Ï´Ù. ºÒÆ÷ÈÁö¹æ»êÀÇ ÀÌ·¯ÇÑ ´Ù¸éÀûÀΠƯ¼ºÀº ¿µ¾çÇÐÀû Á߿伺°ú ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡¼ ´Ù¾çÇÑ ¿ëµµ·Î À¯¿ëÇÏ°Ô È°¿ëµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ÃËÁø¿äÀÎ
´Ù°¡ºÒÆ÷ÈÁö¹æ»ê(PUFA)Àº ƯÈ÷ ³ëÀÎ Àα¸¿¡¼ ÃÖÀûÀÇ °Ç°À» À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, PUFA Áß¿¡¼µµ DHA¿Í °°Àº ¿À¸Þ°¡-3 Áö¹æ»êÀº ³ú °Ç° À¯Áö¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¬±¸¿¡ µû¸£¸é, ÀÌ·¯ÇÑ Áö¹æ»êÀº ÀÎÁö ±â´É À¯Áö, Ä¡¸Å À§Çè °¨¼Ò, ³ëÀÎÀÇ ±â¾ï·Â Çâ»ó¿¡ ±â¿©ÇÒ ¼ö ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.
¶ÇÇÑ PUFA, ƯÈ÷ ¿À¸Þ°¡ 3 Áö¹æ»êÀº Ç׿°Áõ ÀÛ¿ëÀ» ³ªÅ¸³»¾î ´Ù¾çÇÑ °Ç° »óŸ¦ °ü¸®Çϰí Àü¹ÝÀûÀÎ À£ºù¿¡ ±â¿©ÇÕ´Ï´Ù. °í·ÉÈ »çȸ·ÎÀÇ Àα¸ Åë°èÇÐÀû º¯È´Â ºÐ¸íÇϸç, Åë°è¿¡ µû¸£¸é ³ëÀÎ Àα¸°¡ ´«¿¡ ¶ç°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, 2020³â¿¡´Â ¹Ì±¹ Àα¸ 6¸í Áß 1¸íÀÌ 65¼¼ ÀÌ»óÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â 1920³â Àα¸ÀÇ 20¸í Áß 1¸í ¹Ì¸¸À̾ú´ø Àα¸ ±¸¼º°ú´Â ´ëÁ¶ÀûÀÔ´Ï´Ù.
ÀÌ·¯ÇÑ ¼¼°è °í·ÉÈ Çö»óÀº ¼¼°è ÃÖ°í·É Àα¸¸¦ º¸À¯ÇÑ °ÍÀ¸·Î ¾Ë·ÁÁø ÀϺ» µî¿¡¼µµ º¼ ¼ö ÀÖ½À´Ï´Ù. ÀϺ»¿¡¼´Â ÇöÀç 10¸í Áß 1¸í ÀÌ»óÀÌ 80¼¼ ÀÌ»óÀ¸·Î °í·ÉÈ ¹°°áÀÇ ÃÖÀü¼±¿¡ À§Ä¡Çϰí ÀÖ½À´Ï´Ù.
ÁøÈÇÏ´Â ¿¬·É ±¸¼ºÀº ³ëÈ¿¡ µû¸¥ °Ç° ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀÇ Çʿ伺À» °Á¶Çϸç PUFA¿Í °°Àº º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù.
½ÉÇ÷°ü Áúȯ, ´ç´¢º´, ½Å°æ ÅðÇ༺ Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ Àü ¼¼°è À¯º´·üÀº ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Áõ»óÀ» °ü¸®Çϰí Àü¹ÝÀûÀÎ °Ç° °á°ú¸¦ °³¼±Çϱâ À§ÇØ °Ç° º¸Á¶ ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ´ç´¢º´ Çùȸ´Â 2021³â ¹Ì±¹ Àα¸ÀÇ 11.6%¿¡ ÇØ´çÇÏ´Â 3,840¸¸ ¸íÀÇ ¹Ì±¹ÀÎÀÌ ´ç´¢º´ Áø´ÜÀ» ¹Þ¾ÒÀ¸¸ç, 10¸í Áß 4¸íÀÌ µÎ °¡Áö ÀÌ»óÀÇ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Ù°í ¹àÇû½À´Ï´Ù. ¸¶Âù°¡Áö·Î ¼¼°èº¸°Ç±â±¸(WHO)´Â Àεµ¿¡¼ 18¼¼ ÀÌ»ó Àα¸ Áß 7,700¸¸ ¸íÀÌ Á¦ 2Çü ´ç´¢º´À» ¾Î°í ÀÖ´Ù°í ÁöÀûÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ³î¶ó¿î ¼öÄ¡´Â °Ç°À» ÁõÁøÇÏ°í ¸¸¼º ÁúȯÀÇ È®»êÀ» ¸·±â À§ÇÑ °³ÀÔÀÌ ½Ã±ÞÈ÷ ÇÊ¿äÇÏ´Ù´Â °ÍÀ» °Á¶ÇÕ´Ï´Ù.
°Ç°¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ °Ç° ÁõÁø ¼ººÐÀÌ Ç³ºÎÇÑ ±â´É¼º ½Äǰ°ú À½·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, PUFA´Â ÀÌ·¯ÇÑ Ãß¼¼ÀÇ ÁÖ¿ªÀ¸·Î ºÎ»óÇÏ¿© °ÈÀ¯ À½·á, ½ºÇÁ·¹µå, Á¦°ú, À¯¾Æ¿ë Á¶Á¦ºÐÀ¯ µî ´Ù¾çÇÑ Á¦Ç°¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¾ïÁ¦¿äÀÎ
´Ù°¡ºÒÆ÷ÈÁö¹æ»êÀº ¾îÀ¯¿Í °°Àº ÇØ¾ç À¯·¡ ¶Ç´Â ÀϺΠ³ó»ê¹°¿¡¼ ÃßÃâÇÑ °ÍÀ¸·Î, ±âÈÄ Á¶°ÇÀ̳ª °ø±Þ¸Á ³» ´Ù¸¥ ºÒÈ®½Ç¼º¿¡ µû¶ó °¡°ÝÀÌ º¯µ¿Çϱ⠽±½À´Ï´Ù. ÀÌ·¯ÇÑ º¯µ¿¼ºÀº PUFA¸¦ »ý»êÇÏ°í ±¸¸ÅÇÏ´Â Á¦Á¶¾÷ü¿Í ¼ÒºñÀÚ ¸ðµÎ¿¡°Ô µµÀüÀÌ µÇ¸ç, PUFA´Â ¿ÜºÎ ¿äÀÎÀÇ ¿µÇâÀ» ¹Þ±â ½±±â ¶§¹®¿¡ Á¦Á¶¾÷ü¿Í ¼ÒºñÀÚ ¸ðµÎ¿¡°Ô ÇÕ¸®ÀûÀÎ °¡°ÝÀ¸·Î PUFA¸¦ °ø±ÞÇÒ ¼ö ÀÖµµ·Ï ¾÷°è ³» ÀûÀÀ Àü·«ÀÌ ÇÊ¿äÇÕ´Ï´Ù.
´Ù°¡ºÒÆ÷ÈÁö¹æ»ê ½ÃÀåÀº ¿À¸Þ°¡ 3¿Í ¿À¸Þ°¡6·Î À¯Çüº°·Î ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù.
PUFA ½ÃÀå ³»¿¡¼ À¯Çüº° ¼¼ºÐÈ´Â ÁÖ·Î ¿À¸Þ°¡ 3¿Í ¿À¸Þ°¡6ÀÇ µÎ °¡Áö ÁÖ¿ä Ä«Å×°í¸®·Î ±¸¼ºµË´Ï´Ù. ¿À¸Þ°¡ 3 Áö¹æ»êÀº ³ª»Û ÄÝ·¹½ºÅ×·Ñ(LDL)À» È¿°úÀûÀ¸·Î ³·Ãß°í ÁÁÀº ÄÝ·¹½ºÅ×·Ñ(HDL)À» Áõ°¡½ÃÄÑ ½ÉÀ庴°ú ³úÁ¹Áß À§ÇèÀ» °¨¼Ò½ÃŰ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ¿À¸Þ°¡ 3°¡ dzºÎÇÑ ±â´É¼º ½Äǰ ¹× À½·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý¸é, ¿À¸Þ°¡6´Â º¸´Ù ´Ù¾çÇÑ ½Äǰ¿¡ ÇÔÀ¯µÇ¾î ÀÖ¾î ÀÏ»ó ½Ä´Ü¿¡¼ º¸´Ù ½±°Ô ¼·ÃëÇÒ ¼ö ÀÖ´Â ¿µ¾ç¼ÒÀÔ´Ï´Ù. ´Ù¾çÇÑ ½Äǰ¿¡ ÇÔÀ¯µÈ ¿À¸Þ°¡6 Áö¹æ»êÀÇ ´Ù¾ç¼ºÀ¸·Î ÀÎÇØ ¿À¸Þ°¡6 Áö¹æ»êÀÇ ¼·Ãë°¡ ´õ¿í ¿ëÀÌÇØÁ³½À´Ï´Ù.
ºÏ¹Ì°¡ ´Ù°¡ºÒÆ÷ÈÁö¹æ»ê ½ÃÀå¿¡¼ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÏ¹Ì´Â PUFA ½ÃÀå¿¡¼ ÁÖ¸ñÇÒ ¸¸ÇÑ À§Ä¡¸¦ Â÷ÁöÇÒ °ÍÀ̸ç, ¿©±â¿¡´Â ¸î °¡Áö °·ÂÇÑ ¿äÀÎÀÌ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ ¿äÀÎ Áß Çϳª´Â PUFA¿Í °ü·ÃµÈ °Ç°»óÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁ³´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀνÄÀÇ Áõ°¡´Â PUFA°¡ °ÈµÈ ½Äǰ, À½·á ¹× º¸ÃæÁ¦¿¡ ´ëÇÑ °·ÂÇÑ ¼ö¿ä¸¦ âÃâÇÏ´Â ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.
ºÏ¹Ì°¡ PUFA ½ÃÀå¿¡¼ ¿ìÀ§¸¦ Á¡Çϰí ÀÖ´Â °¡Àå Å« ¿äÀÎÀº ´Ù¸¥ Áö¿ª¿¡ ºñÇØ ³ôÀº °¡Ã³ºÐ ¼ÒµæÀ» Ư¡À¸·Î ÇÏ´Â ºÏ¹ÌÀÇ ÅºÅºÇÑ °æÁ¦ÀÔ´Ï´Ù. ¼¼°èÀºÇà º¸°í¼¿¡ µû¸£¸é 2021³â ÇöÀç ¹Ì±¹ÀÇ ÃÖÁ¾ ¼ÒºñÁöÃâÀº 19Á¶ 2,600¾ï ´Þ·¯¿¡ ´ÞÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦·ÂÀ¸·Î ÀÎÇØ ¼ÒºñÀÚ´Â PUFA¸¦ Æ÷ÇÔÇÑ °Ç° ¹× À£ºù Á¦Ç°¿¡ ´õ ¸¹Àº ÀÚ¿øÀ» ÇÒ´çÇÒ ¼ö ÀÖ½À´Ï´Ù. ³ô¾ÆÁø Àνİú °·ÂÇÑ °æÁ¦ »óȲÀÇ Á¶ÇÕÀº PUFA ½ÃÀå Çü¼º¿¡ ÀÖ¾î ºÏ¹ÌÀÇ Áß¿äÇÑ ¿ªÇÒÀ» °Á¶Çϰí ÀÖ½À´Ï´Ù.
ȸ»ç Á¦Ç°
The polyunsaturated fatty acids market is projected to rise at a compound annual growth rate (CAGR) of 8.13% to reach a market valuation of US$18.527 billion by 2029, from US$10.717 billion in 2022.
Polyunsaturated fat, a variant of dietary fat, is classified among the beneficial fats alongside monounsaturated fat. This type of fat is present in both plant and animal sources, including salmon, vegetable oils, and select nuts and seeds. Moderate consumption of polyunsaturated (as well as monounsaturated) fats instead of saturated and trans fats can contribute to overall health.
Polyunsaturated fats include essential fatty acids known as omega-3 and omega-6 fats. These play a crucial role in supporting brain function and cell growth. Since our bodies do not produce essential fatty acids, obtaining them from food sources is imperative. The industry applications of polyunsaturated fatty acids include food, nutraceuticals, pharmaceuticals, and feed applications.
Polyunsaturated fatty acids are categorized by type, with distinctions made between Omega-3 and Omega-6. This differentiation reflects the diverse roles these fatty acids play in promoting health. Furthermore, the polyunsaturated fatty acids market is segmented by form, offering diverse options for consumers. These include tablets, liquids, soft gels, and powders, each catering to varied preferences and ease of consumption. This multifaceted nature of polyunsaturated fats makes them useful for their nutritional significance and their diverse applications in different industries.
Market Drivers
Polyunsaturated fatty acids (PUFAs) are crucial for maintaining optimal health, particularly in the geriatric population. Among PUFAs, omega-3s, such as DHA, play a vital role in supporting brain health. Research suggests that these fatty acids contribute to preserving cognitive function, lowering the risk of dementia, and potentially improving memory in older adults.
Furthermore, PUFAs, especially omega-3s, exhibit anti-inflammatory properties that can help manage various health conditions and contribute to overall well-being. The demographic shift towards an aging population is evident, with statistics indicating a notable increase in the elderly population. In 2020, approximately 1 in 6 individuals in the United States were aged 65 and above, in stark contrast to the demographic composition in 1920, where this age group comprised less than 1 in 20 of the population.
This global aging phenomenon in countries like Japan is known for having the world's oldest population. In Japan, more than 1 in 10 individuals are now aged 80 or older, placing the country at the forefront of the ageing demographic wave.
The evolving age structure underscores the need for solutions that address health concerns associated with aging, leading to an increased demand for supplements such as PUFAs.
The global incidence of chronic diseases, including cardiovascular ailments, diabetes, and neurodegenerative disorders, is steadily increasing, demanding dietary supplements to manage these conditions and enhance overall health outcomes. Statistics highlight the severity of this health challenge, with 6 out of 10 adults in the United States affected by at least one chronic disease, and 4 out of 10 having two or more, as reported by the CDC. In 2021, the American Diabetes Association revealed that 38.4 million Americans, constituting 11.6% of the population, were diagnosed with diabetes. Similarly, the World Health Organization notes that in India, a staggering 77 million individuals above the age of 18 are grappling with type 2 diabetes. These alarming figures underscore the urgent need for interventions that promote health and combat the rising prevalence of chronic diseases.
In response to this growing health crisis, there is a surging demand for functional foods and beverages enriched with health-promoting ingredients. PUFAs are emerging as a key player in this trend, finding applications in various products such as fortified dairy drinks, spreads, baked goods, and infant formula.
Market Restraints
Polyunsaturated fatty acids, derived from marine sources such as fish oil and select agricultural sources, are susceptible to price fluctuations influenced by climate conditions and other uncertainties within the supply chain. These variations pose challenges for both manufacturers and consumers in producing and purchasing PUFAs. The sensitivity of PUFAs to external factors underscores the need for adaptive strategies within the industry to make them affordable for both manufacturers and consumers.
The polyunsaturated fatty acids market is segmented by type, with omega-3 and omega-6.
Within the PUFA market, segmentation by type primarily comprises two main categories: omega-3 and omega-6. Omega-3 fatty acids are recognized for their potential to reduce the risk of heart disease and stroke by effectively lowering bad cholesterol (LDL) while simultaneously elevating good cholesterol (HDL). This has fueled a growing demand for functional foods and beverages enriched with omega-3s. On the other hand, omega-6 is found in a broader spectrum of food sources, rendering them more accessible for incorporation into the daily diet. The versatility of omega-6 fatty acids in various foods enhances their ease of integration.
North America is anticipated to hold a significant share of the polyunsaturated fatty acids market.
North America will hold a notable position in the PUFA market, by several influential factors contribute to this position. One key factor is the heightened general awareness of the health benefits associated with PUFAs. This increased awareness acts as a driving force, generating a robust demand for PUFA-enriched foods, beverages, and supplements within the region.
A significant contributor to North America's dominance in the PUFA market is its robust economy, characterized by higher disposable incomes compared to many other regions. As of 2021, the United States recorded a final consumption expenditure of 19.26 trillion current US dollars, as reported by the World Bank. This economic strength empowers consumers to allocate more resources toward health and wellness products, including those containing PUFAs. The combination of heightened awareness and a strong economic landscape underscores North America's important role in shaping the PUFA market.
Market developments
Company Products
Market Segmentation